133 related articles for article (PubMed ID: 36226361)
1. Dual-energy CT imaging of atherosclerotic plaque using novel ultrasmall superparamagnetic iron oxide in hyperlipidemic rabbits.
Sato H; Fujimoto S; Kawaguchi YO; Nozaki YO; Tomizawa N; Kogure Y; Minamino T
Acta Radiol; 2023 Apr; 64(4):1718-1724. PubMed ID: 36226361
[TBL] [Abstract][Full Text] [Related]
2. MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
Kaneko C; Nitta N; Tsuchiya K; Watanabe S; Nitta-Seko A; Ohta S; Otani H; Sonoda A; Murata K; Shiomi M
Br J Radiol; 2015 Sep; 88(1053):20150167. PubMed ID: 26083261
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.
Sekita A; Unterweger H; Berg S; Ohlmeyer S; Bäuerle T; Zheng KH; Coolen BF; Nederveen AJ; Cabella C; Rossi S; Stroes ESG; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2024; 19():1645-1666. PubMed ID: 38406599
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG
J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of Macrophage Plaque Imaging Using Novel Ultrasmall Superparamagnetic Iron Oxide in Dual Energy CT.
Sato H; Fujimoto S; Kogure Y; Daida H
Eur J Radiol Open; 2018; 5():87-91. PubMed ID: 30069497
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.
Ruehm SG; Corot C; Vogt P; Kolb S; Debatin JF
Circulation; 2001 Jan; 103(3):415-22. PubMed ID: 11157694
[TBL] [Abstract][Full Text] [Related]
7. Negatively charged superparamagnetic iron oxide nanoparticles: a new blood-pooling magnetic resonance contrast agent.
Nitta N; Tsuchiya K; Sonoda A; Ota S; Ushio N; Takahashi M; Murata K; Nohara S
Jpn J Radiol; 2012 Dec; 30(10):832-9. PubMed ID: 23001374
[TBL] [Abstract][Full Text] [Related]
8. Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging.
Uca YO; Hallmann D; Hesse B; Seim C; Stolzenburg N; Pietsch H; Schnorr J; Taupitz M
Mol Imaging Biol; 2021 Jun; 23(3):382-393. PubMed ID: 33289060
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization.
Wagner S; Schnorr J; Ludwig A; Stangl V; Ebert M; Hamm B; Taupitz M
Int J Nanomedicine; 2013; 8():767-79. PubMed ID: 23450179
[TBL] [Abstract][Full Text] [Related]
10. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).
Smith BR; Heverhagen J; Knopp M; Schmalbrock P; Shapiro J; Shiomi M; Moldovan NI; Ferrari M; Lee SC
Biomed Microdevices; 2007 Oct; 9(5):719-27. PubMed ID: 17562181
[TBL] [Abstract][Full Text] [Related]
11. Dual-modality imaging of atherosclerotic plaques using ultrasmall superparamagnetic iron oxide labeled with rhodamine.
Li Y; Pan Y; Wu X; Li Y; Wang H; Zhu H; Jiang L
Nanomedicine (Lond); 2019 Aug; 14(15):1935-1944. PubMed ID: 31355711
[No Abstract] [Full Text] [Related]
12. Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls.
Schmitz SA; Taupitz M; Wagner S; Coupland SE; Gust R; Nikolova A; Wolf KJ
Invest Radiol; 2002 Jul; 37(7):405-11. PubMed ID: 12068163
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment.
Hu ZP; Fang XL; Sheng B; Guo Y; Yu YQ
Vascul Pharmacol; 2020 Apr; 127():106659. PubMed ID: 32068091
[TBL] [Abstract][Full Text] [Related]
14. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
15. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
[TBL] [Abstract][Full Text] [Related]
16. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits.
Ruehm SG; Corot C; Vogt P; Cristina H; Debatin JF
Acad Radiol; 2002 May; 9 Suppl 1():S143-4. PubMed ID: 12019852
[No Abstract] [Full Text] [Related]
18. Investigation of atherosclerotic plaques with MRI at 3 T using ultrasmall superparamagnetic particles of iron oxide.
Priest AN; Ittrich H; Jahntz CL; Kooijman H; Weber C; Adam G
Magn Reson Imaging; 2006 Dec; 24(10):1287-93. PubMed ID: 17145399
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerotic imaging using 4 types of superparamagnetic iron oxides: new possibilities for mannan-coated particles.
Tsuchiya K; Nitta N; Sonoda A; Otani H; Takahashi M; Murata K; Shiomi M; Tabata Y; Nohara S
Eur J Radiol; 2013 Nov; 82(11):1919-25. PubMed ID: 24001603
[TBL] [Abstract][Full Text] [Related]
20. A novel blood-pooling MR contrast agent: Carboxymethyl-diethylaminoethyl dextran magnetite.
Sonoda A; Nitta N; Tsuchiya K; Nitta-Seko A; Ohta S; Otani H; Murata K
Mol Med Rep; 2016 Dec; 14(6):5195-5198. PubMed ID: 27779713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
